Literature DB >> 31411729

Pannexin-1 promotes NLRP3 activation during apoptosis but is dispensable for canonical or noncanonical inflammasome activation.

Kaiwen W Chen1, Benjamin Demarco1, Petr Broz1.   

Abstract

Inflammasomes are multimeric protein complex that assemble in the cytosol upon microbial infection or cellular stress. Upon activation, inflammasomes drive the maturation of proinflammatory cytokines, IL-1β and IL-18, and also activate the pore-forming protein, gasdermin D to initiate a form of lytic cell death known as "pyroptosis". Pannexin-1 is channel-forming glycoprotein that promotes membrane permeability and ATP release during apoptosis; and was implicated in canonical NLRP3 or noncanonical inflammasome activation. Here, by utilizing three different pannexin-1 channel inhibitors and two lines of Panx1-/- macrophages, we provide genetic and pharmacological evidence that pannexin-1 is dispensable for canonical or noncanonical inflammasome activation. In contrast, we demonstrate that pannexin-1 cleavage and resulting channel activity during apoptosis promotes NLRP3 inflammasome activation.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Apoptosis; Caspase-11; Gasdermin; Inflammasomes; NLRP3; Pannexin-1

Mesh:

Substances:

Year:  2019        PMID: 31411729     DOI: 10.1002/eji.201948254

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Detection of Gasdermin Activation and Lytic Cell Death During Pyroptosis and Apoptosis.

Authors:  Benjamin Demarco; Saray Ramos; Petr Broz
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Beyond inflammasomes: emerging function of gasdermins during apoptosis and NETosis.

Authors:  Kaiwen W Chen; Benjamin Demarco; Petr Broz
Journal:  EMBO J       Date:  2019-12-03       Impact factor: 11.598

3.  Endothelial Pannexin 1 Channels Control Inflammation by Regulating Intracellular Calcium.

Authors:  Yang Yang; Leon J Delalio; Angela K Best; Edgar Macal; Jenna Milstein; Iona Donnelly; Ashley M Miller; Martin McBride; Xiaohong Shu; Michael Koval; Brant E Isakson; Scott R Johnstone
Journal:  J Immunol       Date:  2020-04-20       Impact factor: 5.422

4.  Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases.

Authors:  Bowen Zhou; Derek W Abbott
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

Review 5.  Role of the purinergic signaling network in lung ischemia-reperfusion injury.

Authors:  Nathan Haywood; Huy Q Ta; Evan Rotar; Zdravka Daneva; Swapnil K Sonkusare; Victor E Laubach
Journal:  Curr Opin Organ Transplant       Date:  2021-04-01       Impact factor: 2.269

Review 6.  Inflammasome and Mitophagy Connection in Health and Disease.

Authors:  Jae-Min Yuk; Prashanta Silwal; Eun-Kyeong Jo
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

7.  ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome.

Authors:  Xiao-Yan Wu; Jin-Yan Lv; Shi-Qing Zhang; Xin Yi; Zi-Wei Xu; Yuan-Xing Zhi; Bo-Xin Zhao; Jian-Xin Pang; Ken Kin Lam Yung; Shu-Wen Liu; Ping-Zheng Zhou
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

Review 8.  Multiple roles of caspase-8 in cell death, inflammation, and innate immunity.

Authors:  Pontus Orning; Egil Lien
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

Review 9.  Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Authors:  Christopher B Ryder; Hannah C Kondolf; Meghan E O'Keefe; Bowen Zhou; Derek W Abbott
Journal:  J Mol Biol       Date:  2021-08-03       Impact factor: 5.469

10.  Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.

Authors:  Leigh Anne Swayne; Scott R Johnstone; Chen Seng Ng; Juan C Sanchez-Arias; Miranda E Good; Silvia Penuela; Alexander W Lohman; Abigail G Wolpe; Victor E Laubach; Michael Koval; Brant E Isakson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-10       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.